Overview Financials News + Filings Key Docs Ownership
|
|
Lucy Scientific Discovery, Inc.
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Dec-31-21 | Sep-30-21 | Sep-30-20 |
| | 10-Q | S-1/A | 10-Q | S-1/A | S-1 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 0.4 | 0.8 | 0.8 | 0.7 | 0.1 |
| Other operating expenses | | | -0.8 | 0.2 | |
| EBITA | -0.4 | -0.8 | 0.0 | -0.9 | -0.1 |
| Amortization of intangibles | 0.0 | | | | |
| EBIT [+] | -0.4 | -0.8 | 0.0 | -0.9 | -0.1 |
| EBIT growth | -7915.5% | -4.3% | | 906.0% | |
| Interest expense | 0.5 | 0.5 | 0.6 | 0.5 | |
| Interest expense | 0.5 | 0.5 | 0.6 | 0.5 | |
| Other income (expense), net [+] | 0.0 | 0.0 | -0.9 | | 0.0 |
| Change in fair value of warrants | | | 0.2 | | |
| Other | 0.0 | 0.0 | | | |
| Pre-tax income | -0.9 | -1.4 | -1.5 | -1.3 | -0.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -0.9 | -1.4 | -1.5 | -1.3 | -0.1 |
| |
| Basic EPS [+] | ($0.09) | | ($0.15) | | |
| Growth | -40.8% | | | | |
| Diluted EPS [+] | ($0.09) | | ($0.15) | | |
| Growth | -40.8% | | | | |
| |
| Shares outstanding (basic) [+] | 10.4 | | 10.1 | | |
| Growth | 3.0% | | | | |
| Shares outstanding (diluted) [+] | 10.4 | | 10.1 | | |
| Growth | 3.0% | | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|